Recently District Court of The Hague has given a judgement in a case between Sandoz and Glaxo regarding a combination patent owned by Glaxo.
Sandoz requested revocation of Glaxo’s combination patent and supplementary protection certificate (“SPC”) for a composition containing the beta-agonist salmeterol and the corticosteroid fluticasone proprionate for simultaneous inhalation in the treatment of respiratory diseases mainly asthma.
Read full article here
Sandoz requested revocation of Glaxo’s combination patent and supplementary protection certificate (“SPC”) for a composition containing the beta-agonist salmeterol and the corticosteroid fluticasone proprionate for simultaneous inhalation in the treatment of respiratory diseases mainly asthma.
Read full article here
No comments:
Post a Comment